The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Clinical Discovery Awards, 2005Strength training patients with Parkinson’s Disease for Dysphagia
Patients with Parkinson's disease have difficulty swallowing, and this difficulty typically worsens as the disease progresses. When foreign material enters into the airway it is called aspiration and...
-
Biomarkers, 2005Specificity & Sensitivity of Transcranial Ultrasound as Biomarker in Parkinson's Disease
Objective/Rationale:
In recent years transcranial sonography (TCS) has become a widely used method to visualize the brain by applying an ultrasound probe to the temporal bone window of the intact... -
Biomarkers, 2005Longitudinal Assessment of Olfactory Dysfunction in Early PD
The impaired ability to smell (also known as olfaction) is increasingly recognized as a consistent feature of the symptomatology of Parkinson's disease (PD). Moreover, the appearance of olfactory...
-
Biomarkers, 2005Development of Lewy Bodies MRI Imaging Agents for the Early Diagnosis of PD & Related Disorders
Parkinson's disease and related conditions are the most common movement disorders. Pathological studies reveal abundant protein deposits in the affected neurones, mainly formed by the protein alpha...
-
Biomarkers, 2005Reduction of NURR1 mRNA in Human Peripheral Blood Lymphocytes as a Biomarker of PD
Parkinson's disease is a common neurodegenerative disease in adults, affecting over 1 million people in the United States. The neuropathology in the brain has been progressing long before the clinical...
-
Biomarkers, 2005Epigenetic Regulation of the alpha-synuclein Gene as a Biomarker of Susceptibility to PD
Available genetic information in Parkinson's disease does not account for all phenomena in the clinical expressivity of the disease. For example, in the Contursi kindred with the A53T substitution in...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.